|
Marc C. Patterson, M.D.
![]() Marc C. Patterson, M.D.
Location:
Minnesota
SummaryDr. Patterson's major interests include Niemann-Pick disease, type C (NPC) and other lysosomal diseases, and congenital disorders of glycosylation. His research activities have included laboratory studies at the University of Queensland (neuropharmacology) and National Institutes of Health (NIH) (lysosomal diseases [LSDs]). His participation in clinical studies includes therapeutic trials and natural history studies at NIH, Columbia University and Mayo Clinic. He has focused on the development of novel small molecule therapies for LSDs, and was principal investigator of a prospective trial of miglustat in NPC and of a retrospective study of the use of miglustat in NPC in clinical practice. Dr. Patterson is participating in the development of therapeutic protocols for metachromatic dystrophy and globoid cell leukodystrophy. He is a member of the Human Glycosylation Disorders Network, and a member of the Lysosomal Disease Network Steering Committee. Recent publicationsSee a listing of my publications Education
M.D.
–
Awarded under section 6529 of the NY State Education Law
Special Clinical Fellow
Fellowship
Senior Clinical Fellow
–
Pediatric Neurology
Clinical Fellowship
–
Pediatric Neurology
Medical Registrar
–
Pediatrics
Medical Registrar
–
Internal Medicine, Nephrology, Hematology/Oncology
Junior House Officer
–
Internal Medicine, Nephrology, Hematology/Oncology
Rotating Internship
–
Internal Medicine, Pediatrics, Surgery, Psychiatry, Ophthalmology
MB BS
|
Legal restrictions and terms of use applicable to this site
Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.